Efficacy of rTMS in Bipolar Depression

Status Terminated

Clinical Trial Summary

Bipolar Disorder is a common condition that is characterized by periods of mood elevation however periods of chronic and recurring depressive episodes are more common and can be severely disabling. Effective treatments exist, however a significant portion of bipolar depressed patients do not respond to, or have difficulty tolerating many of these interventions. Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulatory technique that is effective in major depression and there is evidence for its efficacy in bipolar depression which needs to be assessed in larger randomized controlled trials. This study is a randomised, double-blind, sham-controlled trial over four weeks. The primary objective is to assess improvement in depressive symptoms in acute bipolar depressed patients on treatment with intermittent Theta-Burst Stimulation (iTBS) in comparison to sham-rTMS.

Clinical Trial Description

rTMS is a treatment that involves stimulating a certain area of the brain with magnetic field pulses. Over time, the magnetic field pulses can gradually change the activity level of the stimulated brain region and help symptoms of bipolar depression. The device used in this study has been approved by Health Canada for therapeutic use since 2002. Participants will complete a screen visit to determine eligibility based on the inclusion/exclusion criteria. If the participants are not eligible, no further study procedures will be conducted. Eligible subjects will be randomized to receive either active iTBS-rTMS or sham rTMS treatment (scalp stimulation with no magnetic pulse) daily for four weeks (20 sessions) to the left dorsolateral prefrontal cortex (DLPFC). All participants will complete a MRI (to target the left DLPFC region of the brain and functional activity), EEG & fNIRS, lab work, and neurocognitive testing prior to the commencement and post rTMS treatment. Efficacy, safety and tolerability will be evaluated at screen visit, during daily rTMS treatments, clinic visits and post rTMS treatment. All participants will have a phone interview two weeks post rTMS treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02749006
Study type	Interventional
Source	University of British Columbia
Contact
Status	Terminated
Phase	N/A
Start date	April 2016
Completion date	December 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03256162` - Ketamine as an Adjunctive Therapy for Major Depression	Phase 1
Recruiting	`NCT03396744` - Bright Light Therapy in the Treatment of Non-seasonal Bipolar Depression	Phase 1/Phase 2
Completed	`NCT01914393` - Pediatric Open-Label Extension Study	Phase 3
Active, not recruiting	`NCT03641300` - Efficacy of Convulsive Therapies for Bipolar Depression	N/A
Completed	`NCT02363738` - 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression	Phase 2
Terminated	`NCT01807741` - Asenapine for Bipolar Depression	Phase 2
Recruiting	`NCT01213121` - Neurophysiologic Changes in Patients With Bipolar Depression	Phase 4
Completed	`NCT01919892` - Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium	Phase 4
Completed	`NCT00762268` - A Trial of SAMe for Treatment-Resistant Bipolar Depression	N/A
Terminated	`NCT00566111` - Ceftriaxone in the Management of Bipolar Depression	N/A
Terminated	`NCT00217217` - Low Field Magnetic Stimulation Treatment for Bipolar Depression	Phase 3
Recruiting	`NCT04998773` - Efficacy and Biomarkers of Response of TBS in Treatment Resistant Depression	N/A
Recruiting	`NCT04939649` - Ketamine as an Adjunctive Therapy for Major Depression (2)	Phase 3
Completed	`NCT03658824` - Behavioural Activation for Bipolar Depression: A Case Series	N/A
Suspended	`NCT03674671` - Ketamine Versus Electroconvulsive Therapy in Depression	Phase 3
Recruiting	`NCT05340686` - Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression	N/A
Recruiting	`NCT05296356` - OSU6162 in Bipolar Depression (OBID)	Phase 2
Recruiting	`NCT03711019` - Efficacy of Convulsive Therapies During Continuation	N/A
Completed	`NCT02088580` - Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients	N/A
Terminated	`NCT00272025` - Treatment Resistant Bipolar Depression	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Efficacy of rTMS in Bipolar Depression — rTMS-BD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms